四物汤汤剂与浓缩颗粒剂治疗卵泡发育不良型月经失调的药动学/药效学等效性评价
研究纳入23名健康志愿者进行随机双交叉药动学比较,另纳入25名卵泡发育不良不孕女性进行药效学评价,以阿魏酸为指标成分。结果显示临床剂量170 mL四物汤汤剂与18 g四物汤浓缩颗粒剂在血中产生相同量的阿魏酸,两者均制备自40 g四物汤,药动学/药效学分析显示生物等效,患者促黄体生成素/促卵泡激素比值由<1恢复正常且症状改善。
要点
- 四物汤汤剂170 mL与浓缩颗粒剂18 g(均源自40 g四物汤)阿魏酸血药水平一致。
- 卵泡发育不良不孕患者初始LH/FSH比值<1,服用四物汤后恢复正常且症状改善。
- 药动学/药效学分析支持四物汤汤剂与浓缩颗粒剂生物等效。
核心结论
- 四物汤汤剂与浓缩颗粒剂(均制备自40 g四物汤)在药动学/药效学分析中显示生物等效。
- 临床剂量170 mL四物汤汤剂与18 g四物汤浓缩颗粒剂在血中产生相同量的阿魏酸。
研究设计与样本
- 随机双交叉药动学比较研究纳入23名健康志愿者,测定四物汤汤剂与浓缩颗粒剂中阿魏酸的药动学等效剂量。
- 药效学研究纳入25名卵泡发育不良不孕女性,评价四物汤对月经失调的药效学效应。
主要发现
- 临床剂量170 mL四物汤汤剂与18 g四物汤浓缩颗粒剂产生相同量的血中阿魏酸。
- 服用四物汤汤剂或浓缩颗粒剂的患者初始LH/FSH比值<1,服药后该值恢复正常且症状均改善。
关键数值与推荐
- 药动学等效剂量:170 mL四物汤汤剂与18 g四物汤浓缩颗粒剂(均来自40 g四物汤)产生相同血阿魏酸水平。
- 药效学指标:卵泡发育不良不孕患者初始LH/FSH比值<1,服用四物汤后恢复正常。
临床怎么用
- 临床可依据药动学等效剂量将四物汤汤剂170 mL与浓缩颗粒剂18 g互换使用。
- 对卵泡发育不良相关月经失调患者,四物汤汤剂或浓缩颗粒剂均可改善LH/FSH比值异常及症状。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
Si-Wu-Tang (SWT), a traditional Chinese formula, is commonly used to relieve menstrual discomfort and climacteric syndrome. Water decoction (WD) and concentrated herbal extract (CHE) are the two most common formulations of traditional Chinese medicine (TCM). However, few studies have reported the equivalency of these two formulations. In this study, 23 healthy volunteers were included to determine the pharmacokinetic (PK) equivalent dosage of WD and CHE, and 25 infertile women with follicular maldevelopment to evaluate the pharmacodynamic (PD) effects on menstrual disorders. The randomized, two-way crossover comparative PK study of SWT-WD and SWT-CHE analyzed the active component, ferulic acid. The results showed that clinical doses of 170 mL SWT-WD and 18 g SWT-CHE produced the same amount of ferulic acid in the blood. The PD study showed that patients who took both of these formulations had an initial luteinizing hormone/follicle-stimulating hormone ratio of <1; however, the value returned to normal and their symptoms all improved after taken SWT. Our results showed that WD and CHE, both prepared from 40 g of SWT, displayed bioequivalence upon PK/PD analysis.
引用
- Lee CJ, Kapelemera AM, Tsai YZ, et al. Evaluating the Therapeutic Efficacy of Si-Wu-Tang Decoction and Concentrated Extract in Follicular Maldevelopment-Related Menstrual Disorders Through Pharmacokinetic/Pharmacodynamic Studies. Front Pharmacol. 2020. PMID: 33013359. doi:10.3389/fphar.2020.01245
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。